2Webster RG, Kawaoka Y, Bean WJ.Vaccination as a strategy to reduce the emergence of amantadine-and rimantadine-resistant strains of A/Chick/Pennsylvania/83(H5N2)influenza virus[J].J Anti Chem, 1986, 18(Suppl B): 157.
3Zlydnikov DM.Study of Rimantadine in the USSR: A review of the literature[J].Reviews of Infectious Diseases, 1981, 3(3): 408.
4Burstein ME.Inhibition of HIV-1 replication by newly developed adamantine-containing polyanionic agents[J].Antiviral Research, 1999, 41: 135.
5Chen F.In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds[J].J Clin Virol, 2004, 31(1): 69.
6Keyser LA, Karl M, Nafziger AN, et al.Comparison of central nervous system adverse events of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients[J].Arch Intern Med, 2000, 160: 1 485.
7Woods JM, Bethell RC, Coates JA, et al.4-guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase and of growth of a wide range of influenza A and B viruses in vitro[J].Anti Agents and Chem, 1993, 37(7): 1 473.
8Agarwal SB, Karavadara N, Khakhkhar V, et al.Bird flu: a diagnostic dilemma in the present scenario[J].Indian Academy of Clin Med, 2004, 5(4): 345.
9Adal KA, Flowers RH, Anglim AM, et al.Prevention of nosocomial influenza[J].Infect Control Hosp Epidemiol, 1996, 17: 641.
10Drinka PJ, Gravenstein S, Schilling M, et al.Duration of antiviral prophylaxis during nursing home outbreaks of influenza A[J].Arch Intern Med, 1998, 158: 2 155.